Narayana Health Achieves Historic HIMSS AMAM Stage 6 Validation, Setting Benchmark in Healthcare Analytics
Narayana Health has achieved HIMSS AMAM Stage 6 validation, becoming the first hospital in the Indian subcontinent to reach this advanced analytics maturity level. The milestone highlights its decade-long focus on data-driven healthcare, AI integration, and improved patient outcomes through predictive intelligence and real-time clinical decision-making systems.
The HIMSS AMAM framework is recognised globally as one of the foremost benchmarks for evaluating how healthcare organisations deploy data, analytics and artificial intelligence to strengthen both clinical performance and patient experience. Structured across seven progressive stages, the model assesses the depth of integration of analytics into everyday healthcare decision-making. Stages 6 and 7 represent highly advanced maturity, where predictive intelligence and near real-time analytics are embedded into clinical and operational workflows at scale.
The validation reflects Narayana Health’s sustained decade-long commitment to building a robust analytics foundation across its healthcare network. Notably, these capabilities have been developed and scaled within the cost-sensitive environment of the Indian healthcare system, where operational efficiency directly impacts patient affordability and outcomes.
Dr. Devi Shetty, Founder and Chairman of Narayana Health, stated that India’s predominantly self-pay healthcare structure significantly influenced the organisation’s early adoption of analytics-led governance. Without insurance buffers, inefficiencies such as poor bed utilisation, avoidable readmissions and extended hospital stays directly increase patient costs. He explained that this reality led the organisation to embed operational and financial precision into every clinical decision, providing senior doctors with detailed visibility into metrics including length of stay, procedural material costs, blood transfusions, surgical re-explorations, mortality, morbidity and infection rates. Over time, this data-driven discipline has contributed to reductions in mortality and morbidity while improving productivity and affordability of care.
Over the years, Narayana Health has transitioned from traditional reporting systems to a fully integrated enterprise-wide analytics ecosystem supporting hundreds of use cases across clinical care, hospital operations and resource planning. The organisation has consistently invested in innovation and digital capability development to strengthen its position within global healthcare transformation toward data-driven care models.
Dr. Emmanuel Rupert, Managing Director and Group Chief Executive Officer of Narayana Health, stated that healthcare systems worldwide are increasingly being reshaped by the responsible use of data. He noted that Narayana Health recognised early that analytics would be central to delivering scalable patient outcomes while remaining aligned with the realities of Indian healthcare delivery. He added that the validation reflects years of sustained effort across teams and reinforces the belief that world-class healthcare innovation can be developed in India for India.
The organisation’s analytics capabilities, powered by Medha AI, now support multiple operational domains including patient flow optimisation, reduced waiting times and improved workforce and bed utilisation. Narayana Health has also developed in-house digital solutions tailored to high-volume clinical workflows. One such system, Medha Scribe, an ambient documentation platform, has been implemented in echocardiography workflows at the Narayana Institute of Cardiac Sciences. The system captures procedural findings in real time and auto-populates reporting fields, significantly reducing report turnaround time while allowing clinicians to maintain uninterrupted workflow continuity. Similar solutions are being extended to radiology, outpatient consultations and operation theatre documentation.
In parallel, structured clinical data systems have enabled the development of India-specific research models and predictive tools, including the NH Pre-Operative Risk Score for coronary artery bypass graft surgeries and artificial intelligence-assisted electrocardiogram models designed for earlier detection of cardiac abnormalities, particularly in resource-constrained environments.
Mr. Vivek Rajagopal, Group Chief Analytics and Artificial Intelligence Officer, stated that the organisation’s focus has been to embed analytics deeply into everyday clinical and operational decision-making rather than treating it as a standalone technological layer. He added that Narayana Health has built a unified ecosystem where clinical, operational and financial insights converge to enable faster and more consistent decision-making across the organisation.
Beyond the validation, the HIMSS AMAM assessment process also strengthened governance frameworks related to analytics implementation, monitoring and accountability. The external evaluation reviewed both technological maturity and measurable real-world outcomes across patient safety, quality of care and resource management. With this recognition, Narayana Health joins a select global group of healthcare organisations achieving this level of analytics maturity, reinforcing its position in building scalable, technology-enabled and patient-centric healthcare systems.
The milestone marks a significant advancement in the integration of analytics into healthcare delivery, highlighting Narayana Health’s continued evolution into a data-driven healthcare enterprise with measurable impact on clinical excellence and operational efficiency.

Comment List